Korsana Biosciences
Biotechnology Research in United States
Overview
Korsana Biosciences is committed to building best-in-class therapeutics with the goal of reducing the burden of neurodegenerative diseases for patients and caregivers. The Company’s lead program, KRSA-028, is a next-generation shuttled antibody targeting amyloid beta for the treatment of Alzheimer’s disease. KRSA-028 leverages Therapeutic Targeting (THETA™), a novel CNS shuttle technology developed in partnership with Paragon Therapeutics and designed to enable dramatically higher drug concentrations in the brain and overcome the limitations of earlier shuttle technologies. In addition, Korsana is advancing a pipeline of innovative therapies for neurodegenerative diseases. For more information, please visit www.korsana.com.
Tagline
Building best-in-class therapeutics with the goal of reducing the burden of neurodegenerative diseases.
EMPLOYEES
11-50 employees
FOUNDED
—
HQ
Waltham, MA
TYPE
Public Company
Location
- Street
- —
- City
- Waltham
- Region
- MA
- Postal code
- —
- Country
- United States
Email patterns
See email patterns for Korsana Biosciences
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
korsana.com is the website of Korsana Biosciences.
What is the industry of the company?
Korsana Biosciences (korsana.com) is in the Biotechnology Research industry.
How many employees does the company have?
Korsana Biosciences (korsana.com) has 11-50 employees.
What is the company type?
The company type of Korsana Biosciences (korsana.com) is Public Company.
Where is the company headquartered?
Korsana Biosciences (korsana.com) is headquartered in Waltham, MA.
What is the address of the company?
The address of Korsana Biosciences (korsana.com) is Waltham, MA, United States.
What are the social media accounts of the company?
The social media account of Korsana Biosciences (korsana.com) is LinkedIn.
Social media